[Basic tricyclic oxyiminoethers and their pharmacological properties].
D000374:Aggression / Q000187:drug effects; D000818:Animals; D000928:Antidepressive Agents / Q000138:chemical synthesis* / Q000494:pharmacology*; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D003864:Depression, Chemical; D003986:Dibenzocycloheptenes / Q000138:chemical synthesis* / Q000494:pharmacology*; D004357:Drug Synergism; D006168:Guinea Pigs; D006801:Humans; D051379:Mice; D009538:Nicotine / Q000037:antagonists & inhibitors; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010830:Physostigmine / Q000037:antagonists & inhibitors; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D013268:Stimulation, Chemical; D014149:Tranquilizing Agents / Q000037:antagonists & inhibitors
D000928:Antidepressive Agents; D003986:Dibenzocycloheptenes; D010276:Parasympatholytics; D014149:Tranquilizing Agents; D009538:Nicotine; D012110:Reserpine; D010830:Physostigmine; D009638:Norepinephrine
Basische tricyclische Oxyiminoäther und ihre pharmakologischen Eigenschaften.